Detalhe da pesquisa
1.
Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
PLoS Med
; 15(9): e1002655, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30265679
2.
Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model.
Antimicrob Agents Chemother
; 60(6): 3759-66, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067321
3.
Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxis.
Antimicrob Agents Chemother
; 59(7): 3913-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25896688
4.
Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.
PLoS One
; 12(10): e0185946, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28982161
5.
Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures.
PLoS One
; 11(6): e0157061, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27275923
6.
An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.
Int J Pharm
; 495(1): 579-587, 2015 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26386138